![A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System | Scientific Reports A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-57202-3/MediaObjects/41598_2019_57202_Fig1_HTML.png)
A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System | Scientific Reports
![PDF] FIGO Staging System for Uterine Cervical Cancer : Enter Cross-sectional Imaging | Semantic Scholar PDF] FIGO Staging System for Uterine Cervical Cancer : Enter Cross-sectional Imaging | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3cd6039e2e77682d9fe2ad2a729c678b6e4c1f93/3-Table1-1.png)
PDF] FIGO Staging System for Uterine Cervical Cancer : Enter Cross-sectional Imaging | Semantic Scholar
![Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer - Gynecologic Oncology Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/416710fb-25ed-4b42-ad69-d637713e771b/gr1_lrg.jpg)
Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer - Gynecologic Oncology
![PDF] FIGO Staging System for Uterine Cervical Cancer : Enter Cross-sectional Imaging | Semantic Scholar PDF] FIGO Staging System for Uterine Cervical Cancer : Enter Cross-sectional Imaging | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3cd6039e2e77682d9fe2ad2a729c678b6e4c1f93/4-Table2-1.png)
PDF] FIGO Staging System for Uterine Cervical Cancer : Enter Cross-sectional Imaging | Semantic Scholar
![Cancers | Free Full-Text | Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? | HTML Cancers | Free Full-Text | Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? | HTML](https://www.mdpi.com/cancers/cancers-12-01552/article_deploy/html/images/cancers-12-01552-g001.png)
Cancers | Free Full-Text | Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? | HTML
![Cancers | Free Full-Text | [F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients | HTML Cancers | Free Full-Text | [F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients | HTML](https://www.mdpi.com/cancers/cancers-14-04382/article_deploy/html/images/cancers-14-04382-g001.png)
Cancers | Free Full-Text | [F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients | HTML
Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previous
![Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis - Abstract - Europe PMC Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis - Abstract - Europe PMC](https://europepmc.org/articles/PMC8247576/bin/fonc-11-682849-g001.jpg)
Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis - Abstract - Europe PMC
![Cancers | Free Full-Text | Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? | HTML Cancers | Free Full-Text | Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? | HTML](https://www.mdpi.com/cancers/cancers-12-01552/article_deploy/html/images/cancers-12-01552-g001-550.jpg)
Cancers | Free Full-Text | Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? | HTML
![Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without - Gynecologic Oncology Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c2c3dadc-a449-4c26-a656-7b59ffbe2b91/gr1_lrg.jpg)
Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without - Gynecologic Oncology
![Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis - Abstract - Europe PMC Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis - Abstract - Europe PMC](https://europepmc.org/articles/PMC8247576/bin/fonc-11-682849-g002.jpg)
Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis - Abstract - Europe PMC
![Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes - Gynecologic Oncology Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/fef6bf80-e23e-4bd1-9921-587ea5f55fdb/gr1.jpg)